132 related articles for article (PubMed ID: 31402899)
21. A potential role for dendritic cell/macrophage-expressing DPP4 in obesity-induced visceral inflammation.
Zhong J; Rao X; Deiuliis J; Braunstein Z; Narula V; Hazey J; Mikami D; Needleman B; Satoskar AR; Rajagopalan S
Diabetes; 2013 Jan; 62(1):149-57. PubMed ID: 22936179
[TBL] [Abstract][Full Text] [Related]
22. Roux-en-Y gastric bypass surgery, but not calorie restriction, reduces plasma branched-chain amino acids in obese women independent of weight loss or the presence of type 2 diabetes.
Lips MA; Van Klinken JB; van Harmelen V; Dharuri HK; 't Hoen PA; Laros JF; van Ommen GJ; Janssen IM; Van Ramshorst B; Van Wagensveld BA; Swank DJ; Van Dielen F; Dane A; Harms A; Vreeken R; Hankemeier T; Smit JW; Pijl H; Willems van Dijk K
Diabetes Care; 2014 Dec; 37(12):3150-6. PubMed ID: 25315204
[TBL] [Abstract][Full Text] [Related]
23. The impact of obesity on secretion of adiponectin multimeric isoforms differs in visceral and subcutaneous adipose tissue.
Kovacova Z; Tencerova M; Roussel B; Wedellova Z; Rossmeislova L; Langin D; Polak J; Stich V
Int J Obes (Lond); 2012 Oct; 36(10):1360-5. PubMed ID: 22143618
[TBL] [Abstract][Full Text] [Related]
24. Hypoxia Alters the Expression of Dipeptidyl Peptidase 4 and Induces Developmental Remodeling of Human Preadipocytes.
Chowdhury HH; Velebit J; Radić N; Frančič V; Kreft M; Zorec R
J Diabetes Res; 2016; 2016():7481470. PubMed ID: 26881257
[TBL] [Abstract][Full Text] [Related]
25. Relationship between hepatic/visceral fat and hepatic insulin resistance in nondiabetic and type 2 diabetic subjects.
Gastaldelli A; Cusi K; Pettiti M; Hardies J; Miyazaki Y; Berria R; Buzzigoli E; Sironi AM; Cersosimo E; Ferrannini E; Defronzo RA
Gastroenterology; 2007 Aug; 133(2):496-506. PubMed ID: 17681171
[TBL] [Abstract][Full Text] [Related]
26. Comparison of Short- and Mid-term Efficacy and the Mechanisms of Gastric Bypass Surgeries on Managing Obese and Nonobese Type 2 Diabetes Mellitus: A Prospective Study.
Zhang X; Cheng Z; Xiao Z; Du X; Du J; Li Y; Long Y; Yu H; Zhang X; Tian H
Arch Med Res; 2015 May; 46(4):303-9. PubMed ID: 26087171
[TBL] [Abstract][Full Text] [Related]
27. Dipeptidyl peptidase inhibitor therapy in type 2 diabetes: Control of the incretin axis and regulation of postprandial glucose and lipid metabolism.
Mulvihill EE
Peptides; 2018 Feb; 100():158-164. PubMed ID: 29412815
[TBL] [Abstract][Full Text] [Related]
28. The fatty acid transporter FAT/CD36 is upregulated in subcutaneous and visceral adipose tissues in human obesity and type 2 diabetes.
Bonen A; Tandon NN; Glatz JF; Luiken JJ; Heigenhauser GJ
Int J Obes (Lond); 2006 Jun; 30(6):877-83. PubMed ID: 16418758
[TBL] [Abstract][Full Text] [Related]
29. Dipeptidyl peptidase IV (DPP4)-deficiency attenuates diet-induced obesity in rats: possible implications for the hypothalamic neuropeptidergic system.
Stephan M; Radicke A; Leutloff S; Schmiedl A; Pabst R; von Hörsten S; Dettmer S; Lotz J; Nave H
Behav Brain Res; 2011 Jan; 216(2):712-8. PubMed ID: 20887754
[TBL] [Abstract][Full Text] [Related]
30. Interrelationship of dipeptidyl peptidase IV (DPP4) with the development of diabetes, dyslipidaemia and nephropathy: a streptozotocin-induced model using wild-type and DPP4-deficient rats.
Kirino Y; Sato Y; Kamimoto T; Kawazoe K; Minakuchi K; Nakahori Y
J Endocrinol; 2009 Jan; 200(1):53-61. PubMed ID: 18931022
[TBL] [Abstract][Full Text] [Related]
31. Increased Plasma Dipeptidyl Peptidase-4 Activities in Patients with Coronary Artery Disease.
Yang G; Li Y; Cui L; Jiang H; Li X; Jin C; Jin D; Zhao G; Jin J; Sun R; Piao L; Xu W; Fang C; Lei Y; Yuan K; Xuan C; Ding D; Cheng X
PLoS One; 2016; 11(9):e0163027. PubMed ID: 27654253
[TBL] [Abstract][Full Text] [Related]
32. Cord serum dipeptidyl-peptidase 4 activity in gestational diabetes.
Al-Aissa Z; Rosta K; Hadarits O; Harreiter J; Zóka A; Bancher-Todesca D; Patócs A; Kiss K; Sármán B; Pusztai P; Sziller I; Rigó J; Rácz K; Somogyi A; Kautzky-Willer A; Firneisz G
Eur J Clin Invest; 2015 Feb; 45(2):196-203. PubMed ID: 25556541
[TBL] [Abstract][Full Text] [Related]
33. Circulating dipeptidyl peptidase-4 activity correlates with measures of hepatocyte apoptosis and fibrosis in non-alcoholic fatty liver disease in type 2 diabetes mellitus and obesity: A dual cohort cross-sectional study.
Williams KH; Vieira De Ribeiro AJ; Prakoso E; Veillard AS; Shackel NA; Brooks B; Bu Y; Cavanagh E; Raleigh J; McLennan SV; McCaughan GW; Keane FM; Zekry A; Gorrell MD; Twigg SM
J Diabetes; 2015 Nov; 7(6):809-19. PubMed ID: 25350950
[TBL] [Abstract][Full Text] [Related]
34. Serum fetuin-A levels in obese and non-obese subjects with and without type 2 diabetes mellitus.
Zhou ZW; Ju HX; Sun MZ; Chen HM; Fu QP; Jiang DM
Clin Chim Acta; 2018 Jan; 476():98-102. PubMed ID: 29174342
[TBL] [Abstract][Full Text] [Related]
35. Association of plasma dipeptidyl peptidase-4 activity with non-alcoholic fatty liver disease in nondiabetic Chinese population.
Zheng T; Chen B; Yang L; Hu X; Zhang X; Liu H; Qin L
Metabolism; 2017 Aug; 73():125-134. PubMed ID: 28637594
[TBL] [Abstract][Full Text] [Related]
36. Increased plasma DPP4 activity is predictive of prediabetes and type 2 diabetes onset in Chinese over a four-year period: result from the China National Diabetes and Metabolic Disorders Study.
Zheng T; Gao Y; Baskota A; Chen T; Ran X; Tian H
J Clin Endocrinol Metab; 2014 Nov; 99(11):E2330-4. PubMed ID: 25029421
[TBL] [Abstract][Full Text] [Related]
37. Systemic Hypoxia Increases the Expression of DPP4 in Preadipocytes of Healthy Human Participants.
Chowdhury HH; Velebit J; Mekjavic IB; Eiken O; Kreft M; Zorec R
Exp Clin Endocrinol Diabetes; 2018 Feb; 126(2):91-95. PubMed ID: 28950392
[TBL] [Abstract][Full Text] [Related]
38. Increased plasma dipeptidyl peptidase 4 activities predict new-onset microalbuminuria in association with its proinflammatory effects in Chinese without diabetes: a four-year prospective study.
Zheng T; Baskota A; Gao Y; Tian H; Yang F
Nephrol Dial Transplant; 2015 Mar; 30(3):460-6. PubMed ID: 25294850
[TBL] [Abstract][Full Text] [Related]
39. Significance of circulatory DPP4 activity in metabolic diseases.
Nargis T; Chakrabarti P
IUBMB Life; 2018 Feb; 70(2):112-119. PubMed ID: 29331088
[TBL] [Abstract][Full Text] [Related]
40. Circulating dipeptidyl peptidase-4 activity is associated with insulin resistance in type 1 diabetic patients.
Blaslov K; Bulum T; Duvnjak L
J Diabetes Complications; 2015 Apr; 29(3):390-4. PubMed ID: 25641023
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
